Severe Injection Site Reaction to Insulin Detemir
- Ian R. Blumer, MD, FRCP
- From the Charles H. Best Diabetes Centre, Ajax, Ontario, Canada
- Address correspondence to Dr. Ian R. Blumer, 401-95 Bayly St. West, Ajax, ON, Canada. E-mail: ian{at}ianblumer.com
Insulin detemir is a new long-acting insulin analog. Though generally well tolerated, injection site reactions have been reported in 2% of insulin detemir users (1). Most commonly, these untoward reactions manifest as mild injection site erythema or discomfort and seldom lead to discontinuation of the product. Herein, I report the case of a patient with a severe local reaction to insulin detemir necessitating its withdrawl.
A 37-year-old Caucasian woman with a 25-year history of type 1 diabetes was switched from NPH (Humulin …
